Syaloset 2000 Syringe Hyaluronic Acid 1.5% 2ml

Syaloset injected directly into the joint, carries out a viscosuppletive action improving the properties of the joint. lubricants and shock absorption of the synovial fluid. &` a new generation product which, administered under medical observation, restores the viscosity of the product. of the synovial fluid, allowing a return to normal activities.

Composition
Sodium hyaluronate: 16 mg Sodium chloride: 8.5 mg Dibasic sodium phosphate dihydrate : 0.563 mg Monobasic sodium phosphate monohydrate: 0.0045 mg, Water for injections to taste at 1 ml Syaloset is produced in an aseptic environment and terminally sterilized.

Mode instructions for use
Aspirate any joint effusion before proceeding with the injection. Insert a sterile needle of diameter (18 G) onto the syringe. Screw the needle firmly onto the neck of the syringe to ensure a watertight seal and then withdraw the sterile hyaluronic acid solution from the vial. Replace the needle with a suitable sterile needle (21 G) and screw the needle firmly to the collar of the syringe to ensure a watertight seal and prevent leakage of the liquid during administration and then inject Syaloset into the arthritic joint. Inject only into the synovial space. is It is recommended to repeat the knee treatment after 3-6 weeks in order to obtain a long-term improvement in symptoms. The opportunity and the frequency with which you can repeating the treatment cycle must be evaluated by the doctor for each individual patient, considering in each case the risk/benefit ratio of the treatment. For the hip joint, it is recommended to inject the product under ultrasound guidance.

Warnings
the administration of the product must be carried out exclusively by medical specialists.
All rules regarding asepsis and injection techniques must be observed. If it is If there is a spillage, remove it before administering the product.
Do not mix Syaloset with disinfectants such as quaternary ammonium salts or chlorhexidine as they can a precipitate forms. Avoid the simultaneous administration of Sualoset with other products for intra-articular use, in order to prevent any possible interaction.
The device is intended for single use only and the contents must be used immediately after aspiration, removing any air bubbles.
The injection point must be on healthy skin.
Do not inject vascularly.
/>Do not inject outside the cavity. joint, in the synovial tissue or in the joint capsule.
Do not administer Syaloset in the presence of a large intra-articular effusion.
After the intra-articular injection, advise the patient to avoid all activities. intense physical activity and to resume normal activities. only after a few days.